Paul Hastings
DirectoratenGene Therapeutics· In the 2023 proxy
Paul Hastings sits on 4 public boards.
Experience
- enGene TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -92%
- Proteolix, Inc.Public company
- Director? – PresentNo stock prices for these years
- RelypsaPublic company
- Director? – PresentNo stock prices for these years
- ViaCell, Inc.Public company
- Director? – PresentNo stock prices for these years
- ViaCyte, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?